INCY - Xencor falls after royalty sale to Canada's OMERS
2023-11-08 15:07:59 ET
More on Xencor
- Xencor, Inc. (XNCR) Q3 2023 Earnings Call Transcript
- Xencor: Data In Early 2024 Could Bring Shareholder Value
- Xencor: A Mid-Stage Clinical Company With Falling Losses
- Xencor GAAP EPS of -$0.40 beats by $0.31, revenue of $59.16M beats by $29.13M
- Xencor finance chief to step down
For further details see:
Xencor falls after royalty sale to Canada’s OMERS